NCT06551259View on ClinicalTrials.gov

Effect of Dexmedetomidine on Central Nervous System Complications in Patients Undergoing Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

July 30, 2024

Study Completion Date

August 30, 2024

Conditions
Randomized Controlled TrialDexmedetomidine
Interventions
DRUG

Dexmedetomidine

Intravenous infusion of 0.6μg/kg load dose of dexmedetomidine within 10 minutes after intubation, followed by continuous infusion at a rate of 0.4 μg/kg/h until 30 minutes before the end of surgery

DRUG

physiological saline

physiological saline

Trial Locations (1)

Unknown

Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER

NCT06551259 - Effect of Dexmedetomidine on Central Nervous System Complications in Patients Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter